Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F1JY
|
||||
Former ID |
DIB007825
|
||||
Drug Name |
LAS-186323
|
||||
Synonyms |
DHODH inhibitor (autoimmune disease), Alimirall; DHODH inhibitor (rheumatoid arthritis/multiple sclerosis), Almirall
|
||||
Indication | Multiple scierosis [ICD9: 340; ICD10:G35] | Phase 1 | [548790] | ||
Company |
Almirall Prodesfarma SA
|
||||
Target and Pathway | |||||
Target(s) | Dihydroorotate dehydrogenase | Target Info | Inhibitor | [550281] | |
KEGG Pathway | Pyrimidine metabolism | ||||
Metabolic pathways | |||||
PANTHER Pathway | De novo pyrimidine ribonucleotides biosythesis | ||||
PathWhiz Pathway | Pyrimidine Metabolism | ||||
Reactome | Pyrimidine biosynthesis | ||||
WikiPathways | Metabolism of nucleotides | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.